相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma
Kevin D. Courtney et al.
CLINICAL CANCER RESEARCH (2020)
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
A. Y. Shah et al.
EUROPEAN JOURNAL OF CANCER (2019)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature
Daniele Minardi et al.
CURRENT UROLOGY REPORTS (2015)
Arterial Spin Labeling MRI: Clinical Applications in the Brain
Nicholas A. Telischak et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
MRI Assessment of Early Tumor Response in Metastatic Renal Cell Carcinoma Patients Treated With Sorafenib
Hyunseon Christine Kang et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Arterial Spin-labeling MR Imaging of Renal Masses: Correlation with Histopathologic Findings
Rotem S. Lanzman et al.
RADIOLOGY (2012)
Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression
Liang Zhang et al.
PLOS ONE (2011)
Renal Cancer Resistance to Antiangiogenic Therapy Is Delayed by Restoration of Angiostatic Signaling
Rupal S. Bhatt et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Magnetic Resonance Imaging as a Biomarker in Renal Cell Carcinoma
Ivan Pedrosa et al.
CANCER (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Resistance to targeted therapy in renal-cell carcinoma
Brian I. Rini et al.
LANCET ONCOLOGY (2009)
Strategies for Reducing Respiratory Motion Artifacts in Renal Perfusion Imaging With Arterial Spin Labeling
Philip M. Robson et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Does Arterial Spin-labeling MR Imaging-measured Tumor Perfusion Correlate with Renal Cell Cancer Response to Antiangiogenic Therapy in a Mouse Model?
Rachel Schor-Bardach et al.
RADIOLOGY (2009)
Magnetic resonance imaging - Measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma
Cedric de Bazelaire et al.
CLINICAL CANCER RESEARCH (2008)
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma
Olwen M. Hahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma
Mark A. Rosen et al.
CLINICAL CANCER RESEARCH (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
分享论文
